(Q42995214)

English

Cardiometabolic effects of rosiglitazone in patients with type 2 diabetes and coronary artery bypass grafts: A randomized placebo-controlled clinical trial

scientific article published on 11 June 2010

In more languages
default for all languages
No label defined

No description defined

Statements

Cardiometabolic effects of rosiglitazone in patients with type 2 diabetes and coronary artery bypass grafts: A randomized placebo-controlled clinical trial (English)
Olivier F Bertrand
Stéphane Rinfret
Lawrence M Title
Natalie Alméras
Olivier Costerousse
Robert De Larochellière
VICTORY Trial Investigators

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit